nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—CYP2E1—Dacarbazine—pancreatic cancer	0.0441	0.0628	CbGbCtD
Pimozide—KCNH2—Sunitinib—pancreatic cancer	0.0398	0.0567	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0363	0.0517	CbGbCtD
Pimozide—CYP3A7—Tamoxifen—pancreatic cancer	0.0363	0.0517	CbGbCtD
Pimozide—CYP2E1—Tamoxifen—pancreatic cancer	0.0351	0.05	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0279	0.0397	CbGbCtD
Pimozide—CYP3A7—Irinotecan—pancreatic cancer	0.0279	0.0397	CbGbCtD
Pimozide—CYP3A5—Tamoxifen—pancreatic cancer	0.0273	0.0388	CbGbCtD
Pimozide—CYP1A2—Dacarbazine—pancreatic cancer	0.0255	0.0363	CbGbCtD
Pimozide—CYP3A5—Erlotinib—pancreatic cancer	0.0232	0.033	CbGbCtD
Pimozide—CYP2C19—Tamoxifen—pancreatic cancer	0.022	0.0313	CbGbCtD
Pimozide—CYP3A5—Irinotecan—pancreatic cancer	0.0209	0.0298	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0205	0.0291	CbGbCtD
Pimozide—CYP3A7—Docetaxel—pancreatic cancer	0.0205	0.0291	CbGbCtD
Pimozide—CYP3A7—Sunitinib—pancreatic cancer	0.0204	0.029	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0204	0.029	CbGbCtD
Pimozide—CYP1A2—Tamoxifen—pancreatic cancer	0.0203	0.0289	CbGbCtD
Pimozide—ABCB1—Tamoxifen—pancreatic cancer	0.0177	0.0253	CbGbCtD
Pimozide—CYP1A2—Erlotinib—pancreatic cancer	0.0173	0.0246	CbGbCtD
Pimozide—CYP2D6—Tamoxifen—pancreatic cancer	0.0167	0.0238	CbGbCtD
Pimozide—CYP3A5—Docetaxel—pancreatic cancer	0.0153	0.0218	CbGbCtD
Pimozide—ABCB1—Gemcitabine—pancreatic cancer	0.0153	0.0218	CbGbCtD
Pimozide—CYP3A5—Sunitinib—pancreatic cancer	0.0153	0.0217	CbGbCtD
Pimozide—ABCB1—Erlotinib—pancreatic cancer	0.0151	0.0215	CbGbCtD
Pimozide—CYP1A2—Fluorouracil—pancreatic cancer	0.015	0.0213	CbGbCtD
Pimozide—CYP2D6—Erlotinib—pancreatic cancer	0.0142	0.0202	CbGbCtD
Pimozide—ABCB1—Irinotecan—pancreatic cancer	0.0136	0.0194	CbGbCtD
Pimozide—CYP3A4—Tamoxifen—pancreatic cancer	0.0106	0.0151	CbGbCtD
Pimozide—ABCB1—Docetaxel—pancreatic cancer	0.00999	0.0142	CbGbCtD
Pimozide—ABCB1—Sunitinib—pancreatic cancer	0.00994	0.0142	CbGbCtD
Pimozide—CYP3A4—Erlotinib—pancreatic cancer	0.00904	0.0129	CbGbCtD
Pimozide—CYP3A4—Irinotecan—pancreatic cancer	0.00816	0.0116	CbGbCtD
Pimozide—ABCB1—Doxorubicin—pancreatic cancer	0.00744	0.0106	CbGbCtD
Pimozide—CYP2D6—Doxorubicin—pancreatic cancer	0.00701	0.00998	CbGbCtD
Pimozide—CYP3A4—Docetaxel—pancreatic cancer	0.00598	0.00852	CbGbCtD
Pimozide—CYP3A4—Sunitinib—pancreatic cancer	0.00596	0.00848	CbGbCtD
Pimozide—CYP3A4—Doxorubicin—pancreatic cancer	0.00446	0.00635	CbGbCtD
Pimozide—HTR2A—enteric nervous system—pancreatic cancer	0.00135	0.277	CbGeAlD
Pimozide—CACNA1G—digestive system—pancreatic cancer	0.00039	0.0798	CbGeAlD
Pimozide—CALM2—gall bladder—pancreatic cancer	0.000325	0.0665	CbGeAlD
Pimozide—Weight decreased—Docetaxel—pancreatic cancer	0.000324	0.00242	CcSEcCtD
Pimozide—Syncope—Irinotecan—pancreatic cancer	0.000324	0.00242	CcSEcCtD
Pimozide—Insomnia—Sunitinib—pancreatic cancer	0.000324	0.00242	CcSEcCtD
Pimozide—Leukopenia—Irinotecan—pancreatic cancer	0.000324	0.00241	CcSEcCtD
Pimozide—Anaemia—Fluorouracil—pancreatic cancer	0.00032	0.00239	CcSEcCtD
Pimozide—Loss of consciousness—Irinotecan—pancreatic cancer	0.000318	0.00237	CcSEcCtD
Pimozide—Leukopenia—Gemcitabine—pancreatic cancer	0.000315	0.00235	CcSEcCtD
Pimozide—Hypertension—Irinotecan—pancreatic cancer	0.000312	0.00233	CcSEcCtD
Pimozide—Decreased appetite—Sunitinib—pancreatic cancer	0.000311	0.00232	CcSEcCtD
Pimozide—Leukopenia—Fluorouracil—pancreatic cancer	0.00031	0.00231	CcSEcCtD
Pimozide—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000309	0.00231	CcSEcCtD
Pimozide—Constipation—Sunitinib—pancreatic cancer	0.000306	0.00229	CcSEcCtD
Pimozide—Hypertension—Gemcitabine—pancreatic cancer	0.000304	0.00227	CcSEcCtD
Pimozide—Asthenia—Tamoxifen—pancreatic cancer	0.0003	0.00224	CcSEcCtD
Pimozide—Convulsion—Fluorouracil—pancreatic cancer	0.0003	0.00224	CcSEcCtD
Pimozide—Chest pain—Gemcitabine—pancreatic cancer	0.0003	0.00224	CcSEcCtD
Pimozide—Myalgia—Gemcitabine—pancreatic cancer	0.0003	0.00224	CcSEcCtD
Pimozide—Agranulocytosis—Docetaxel—pancreatic cancer	0.000298	0.00223	CcSEcCtD
Pimozide—Increased appetite—Epirubicin—pancreatic cancer	0.000298	0.00222	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000298	0.00222	CcSEcCtD
Pimozide—Asthenia—Erlotinib—pancreatic cancer	0.000297	0.00221	CcSEcCtD
Pimozide—Pruritus—Tamoxifen—pancreatic cancer	0.000296	0.00221	CcSEcCtD
Pimozide—Myalgia—Fluorouracil—pancreatic cancer	0.000295	0.0022	CcSEcCtD
Pimozide—Chest pain—Fluorouracil—pancreatic cancer	0.000295	0.0022	CcSEcCtD
Pimozide—Pruritus—Erlotinib—pancreatic cancer	0.000293	0.00218	CcSEcCtD
Pimozide—Shock—Irinotecan—pancreatic cancer	0.00029	0.00217	CcSEcCtD
Pimozide—Nervous system disorder—Irinotecan—pancreatic cancer	0.000289	0.00216	CcSEcCtD
Pimozide—Diarrhoea—Tamoxifen—pancreatic cancer	0.000286	0.00213	CcSEcCtD
Pimozide—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000285	0.00213	CcSEcCtD
Pimozide—Diarrhoea—Erlotinib—pancreatic cancer	0.000283	0.00211	CcSEcCtD
Pimozide—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000282	0.0021	CcSEcCtD
Pimozide—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000282	0.0021	CcSEcCtD
Pimozide—Anorexia—Irinotecan—pancreatic cancer	0.000281	0.0021	CcSEcCtD
Pimozide—Hyponatraemia—Epirubicin—pancreatic cancer	0.000281	0.0021	CcSEcCtD
Pimozide—Skin disorder—Gemcitabine—pancreatic cancer	0.000279	0.00208	CcSEcCtD
Pimozide—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000278	0.00207	CcSEcCtD
Pimozide—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000277	0.00207	CcSEcCtD
Pimozide—Visual impairment—Docetaxel—pancreatic cancer	0.000277	0.00206	CcSEcCtD
Pimozide—Dizziness—Tamoxifen—pancreatic cancer	0.000277	0.00206	CcSEcCtD
Pimozide—Tachycardia—Fluorouracil—pancreatic cancer	0.000276	0.00206	CcSEcCtD
Pimozide—Hypotension—Irinotecan—pancreatic cancer	0.000276	0.00206	CcSEcCtD
Pimozide—Increased appetite—Doxorubicin—pancreatic cancer	0.000276	0.00206	CcSEcCtD
Pimozide—Anorexia—Gemcitabine—pancreatic cancer	0.000274	0.00204	CcSEcCtD
Pimozide—Dizziness—Erlotinib—pancreatic cancer	0.000274	0.00204	CcSEcCtD
Pimozide—CALM3—islet of Langerhans—pancreatic cancer	0.000271	0.0555	CbGeAlD
Pimozide—Anorexia—Fluorouracil—pancreatic cancer	0.000269	0.00201	CcSEcCtD
Pimozide—Hypotension—Gemcitabine—pancreatic cancer	0.000269	0.002	CcSEcCtD
Pimozide—Eye disorder—Docetaxel—pancreatic cancer	0.000268	0.002	CcSEcCtD
Pimozide—Insomnia—Irinotecan—pancreatic cancer	0.000267	0.00199	CcSEcCtD
Pimozide—Cardiac disorder—Docetaxel—pancreatic cancer	0.000266	0.00199	CcSEcCtD
Pimozide—Vomiting—Tamoxifen—pancreatic cancer	0.000266	0.00198	CcSEcCtD
Pimozide—Hypotension—Fluorouracil—pancreatic cancer	0.000264	0.00197	CcSEcCtD
Pimozide—Rash—Tamoxifen—pancreatic cancer	0.000264	0.00197	CcSEcCtD
Pimozide—Dermatitis—Tamoxifen—pancreatic cancer	0.000263	0.00197	CcSEcCtD
Pimozide—Vomiting—Erlotinib—pancreatic cancer	0.000263	0.00196	CcSEcCtD
Pimozide—Somnolence—Irinotecan—pancreatic cancer	0.000262	0.00196	CcSEcCtD
Pimozide—Headache—Tamoxifen—pancreatic cancer	0.000262	0.00195	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000262	0.00195	CcSEcCtD
Pimozide—Rash—Erlotinib—pancreatic cancer	0.000261	0.00195	CcSEcCtD
Pimozide—Dermatitis—Erlotinib—pancreatic cancer	0.000261	0.00194	CcSEcCtD
Pimozide—Hyponatraemia—Doxorubicin—pancreatic cancer	0.00026	0.00194	CcSEcCtD
Pimozide—Insomnia—Gemcitabine—pancreatic cancer	0.00026	0.00194	CcSEcCtD
Pimozide—Headache—Erlotinib—pancreatic cancer	0.000259	0.00193	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000257	0.00192	CcSEcCtD
Pimozide—Asthenia—Sunitinib—pancreatic cancer	0.000257	0.00192	CcSEcCtD
Pimozide—Decreased appetite—Irinotecan—pancreatic cancer	0.000256	0.00191	CcSEcCtD
Pimozide—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000256	0.00191	CcSEcCtD
Pimozide—Insomnia—Fluorouracil—pancreatic cancer	0.000256	0.00191	CcSEcCtD
Pimozide—Somnolence—Gemcitabine—pancreatic cancer	0.000255	0.00191	CcSEcCtD
Pimozide—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000255	0.0019	CcSEcCtD
Pimozide—Pruritus—Sunitinib—pancreatic cancer	0.000253	0.00189	CcSEcCtD
Pimozide—Breast disorder—Epirubicin—pancreatic cancer	0.000253	0.00189	CcSEcCtD
Pimozide—Constipation—Irinotecan—pancreatic cancer	0.000252	0.00188	CcSEcCtD
Pimozide—Mental disorder—Docetaxel—pancreatic cancer	0.000251	0.00188	CcSEcCtD
Pimozide—Somnolence—Fluorouracil—pancreatic cancer	0.000251	0.00187	CcSEcCtD
Pimozide—Decreased appetite—Gemcitabine—pancreatic cancer	0.00025	0.00186	CcSEcCtD
Pimozide—Nausea—Tamoxifen—pancreatic cancer	0.000248	0.00185	CcSEcCtD
Pimozide—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000248	0.00185	CcSEcCtD
Pimozide—Constipation—Gemcitabine—pancreatic cancer	0.000246	0.00183	CcSEcCtD
Pimozide—Nausea—Erlotinib—pancreatic cancer	0.000246	0.00183	CcSEcCtD
Pimozide—Decreased appetite—Fluorouracil—pancreatic cancer	0.000246	0.00183	CcSEcCtD
Pimozide—Diarrhoea—Sunitinib—pancreatic cancer	0.000245	0.00183	CcSEcCtD
Pimozide—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000244	0.00182	CcSEcCtD
Pimozide—Dysphagia—Epirubicin—pancreatic cancer	0.000242	0.0018	CcSEcCtD
Pimozide—Muscle spasms—Docetaxel—pancreatic cancer	0.00024	0.00179	CcSEcCtD
Pimozide—Eosinophilia—Epirubicin—pancreatic cancer	0.00024	0.00179	CcSEcCtD
Pimozide—Dizziness—Sunitinib—pancreatic cancer	0.000237	0.00177	CcSEcCtD
Pimozide—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000237	0.00176	CcSEcCtD
Pimozide—Breast disorder—Doxorubicin—pancreatic cancer	0.000234	0.00175	CcSEcCtD
Pimozide—Anaemia—Docetaxel—pancreatic cancer	0.000231	0.00172	CcSEcCtD
Pimozide—Pancytopenia—Epirubicin—pancreatic cancer	0.00023	0.00171	CcSEcCtD
Pimozide—Vomiting—Sunitinib—pancreatic cancer	0.000228	0.0017	CcSEcCtD
Pimozide—Rash—Sunitinib—pancreatic cancer	0.000226	0.00168	CcSEcCtD
Pimozide—Dermatitis—Sunitinib—pancreatic cancer	0.000226	0.00168	CcSEcCtD
Pimozide—Urticaria—Fluorouracil—pancreatic cancer	0.000224	0.00167	CcSEcCtD
Pimozide—Headache—Sunitinib—pancreatic cancer	0.000224	0.00167	CcSEcCtD
Pimozide—Syncope—Docetaxel—pancreatic cancer	0.000224	0.00167	CcSEcCtD
Pimozide—Dysphagia—Doxorubicin—pancreatic cancer	0.000224	0.00167	CcSEcCtD
Pimozide—Leukopenia—Docetaxel—pancreatic cancer	0.000224	0.00167	CcSEcCtD
Pimozide—Pollakiuria—Epirubicin—pancreatic cancer	0.000223	0.00167	CcSEcCtD
Pimozide—Eosinophilia—Doxorubicin—pancreatic cancer	0.000222	0.00165	CcSEcCtD
Pimozide—Palpitations—Docetaxel—pancreatic cancer	0.000221	0.00165	CcSEcCtD
Pimozide—Weight increased—Epirubicin—pancreatic cancer	0.00022	0.00164	CcSEcCtD
Pimozide—Loss of consciousness—Docetaxel—pancreatic cancer	0.00022	0.00164	CcSEcCtD
Pimozide—Weight decreased—Epirubicin—pancreatic cancer	0.000219	0.00163	CcSEcCtD
Pimozide—Convulsion—Docetaxel—pancreatic cancer	0.000217	0.00162	CcSEcCtD
Pimozide—Hypertension—Docetaxel—pancreatic cancer	0.000216	0.00161	CcSEcCtD
Pimozide—Drowsiness—Epirubicin—pancreatic cancer	0.000216	0.00161	CcSEcCtD
Pimozide—CALM2—islet of Langerhans—pancreatic cancer	0.000213	0.0436	CbGeAlD
Pimozide—Chest pain—Docetaxel—pancreatic cancer	0.000213	0.00159	CcSEcCtD
Pimozide—Myalgia—Docetaxel—pancreatic cancer	0.000213	0.00159	CcSEcCtD
Pimozide—Nausea—Sunitinib—pancreatic cancer	0.000213	0.00159	CcSEcCtD
Pimozide—Pancytopenia—Doxorubicin—pancreatic cancer	0.000213	0.00159	CcSEcCtD
Pimozide—CALM1—islet of Langerhans—pancreatic cancer	0.000212	0.0434	CbGeAlD
Pimozide—Asthenia—Irinotecan—pancreatic cancer	0.000212	0.00158	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000211	0.00158	CcSEcCtD
Pimozide—Dry mouth—Docetaxel—pancreatic cancer	0.000208	0.00155	CcSEcCtD
Pimozide—Sweating—Epirubicin—pancreatic cancer	0.000207	0.00154	CcSEcCtD
Pimozide—Pollakiuria—Doxorubicin—pancreatic cancer	0.000207	0.00154	CcSEcCtD
Pimozide—Asthenia—Gemcitabine—pancreatic cancer	0.000206	0.00154	CcSEcCtD
Pimozide—Weight increased—Doxorubicin—pancreatic cancer	0.000204	0.00152	CcSEcCtD
Pimozide—Pruritus—Gemcitabine—pancreatic cancer	0.000203	0.00152	CcSEcCtD
Pimozide—Weight decreased—Doxorubicin—pancreatic cancer	0.000202	0.00151	CcSEcCtD
Pimozide—Diarrhoea—Irinotecan—pancreatic cancer	0.000202	0.00151	CcSEcCtD
Pimozide—Agranulocytosis—Epirubicin—pancreatic cancer	0.000201	0.0015	CcSEcCtD
Pimozide—Shock—Docetaxel—pancreatic cancer	0.000201	0.0015	CcSEcCtD
Pimozide—Nervous system disorder—Docetaxel—pancreatic cancer	0.0002	0.00149	CcSEcCtD
Pimozide—Pruritus—Fluorouracil—pancreatic cancer	0.0002	0.00149	CcSEcCtD
Pimozide—Drowsiness—Doxorubicin—pancreatic cancer	0.0002	0.00149	CcSEcCtD
Pimozide—Tachycardia—Docetaxel—pancreatic cancer	0.000199	0.00149	CcSEcCtD
Pimozide—Skin disorder—Docetaxel—pancreatic cancer	0.000198	0.00148	CcSEcCtD
Pimozide—Diarrhoea—Gemcitabine—pancreatic cancer	0.000197	0.00147	CcSEcCtD
Pimozide—Dizziness—Irinotecan—pancreatic cancer	0.000195	0.00146	CcSEcCtD
Pimozide—Anorexia—Docetaxel—pancreatic cancer	0.000194	0.00145	CcSEcCtD
Pimozide—Diarrhoea—Fluorouracil—pancreatic cancer	0.000193	0.00144	CcSEcCtD
Pimozide—KCNH2—islet of Langerhans—pancreatic cancer	0.000193	0.0395	CbGeAlD
Pimozide—Sweating—Doxorubicin—pancreatic cancer	0.000191	0.00143	CcSEcCtD
Pimozide—CALM3—pancreas—pancreatic cancer	0.000191	0.039	CbGeAlD
Pimozide—Hypotension—Docetaxel—pancreatic cancer	0.000191	0.00142	CcSEcCtD
Pimozide—Connective tissue disorder—Epirubicin—pancreatic cancer	0.00019	0.00142	CcSEcCtD
Pimozide—Vomiting—Irinotecan—pancreatic cancer	0.000188	0.0014	CcSEcCtD
Pimozide—Dizziness—Fluorouracil—pancreatic cancer	0.000187	0.00139	CcSEcCtD
Pimozide—Visual impairment—Epirubicin—pancreatic cancer	0.000187	0.00139	CcSEcCtD
Pimozide—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000186	0.00139	CcSEcCtD
Pimozide—Rash—Irinotecan—pancreatic cancer	0.000186	0.00139	CcSEcCtD
Pimozide—Dermatitis—Irinotecan—pancreatic cancer	0.000186	0.00139	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000186	0.00139	CcSEcCtD
Pimozide—Headache—Irinotecan—pancreatic cancer	0.000185	0.00138	CcSEcCtD
Pimozide—Insomnia—Docetaxel—pancreatic cancer	0.000184	0.00138	CcSEcCtD
Pimozide—Vomiting—Gemcitabine—pancreatic cancer	0.000183	0.00136	CcSEcCtD
Pimozide—Somnolence—Docetaxel—pancreatic cancer	0.000181	0.00135	CcSEcCtD
Pimozide—Rash—Gemcitabine—pancreatic cancer	0.000181	0.00135	CcSEcCtD
Pimozide—Dermatitis—Gemcitabine—pancreatic cancer	0.000181	0.00135	CcSEcCtD
Pimozide—Eye disorder—Epirubicin—pancreatic cancer	0.000181	0.00135	CcSEcCtD
Pimozide—Headache—Gemcitabine—pancreatic cancer	0.00018	0.00134	CcSEcCtD
Pimozide—Cardiac disorder—Epirubicin—pancreatic cancer	0.00018	0.00134	CcSEcCtD
Pimozide—Vomiting—Fluorouracil—pancreatic cancer	0.00018	0.00134	CcSEcCtD
Pimozide—Rash—Fluorouracil—pancreatic cancer	0.000178	0.00133	CcSEcCtD
Pimozide—Dermatitis—Fluorouracil—pancreatic cancer	0.000178	0.00133	CcSEcCtD
Pimozide—Decreased appetite—Docetaxel—pancreatic cancer	0.000177	0.00132	CcSEcCtD
Pimozide—Headache—Fluorouracil—pancreatic cancer	0.000177	0.00132	CcSEcCtD
Pimozide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000176	0.00131	CcSEcCtD
Pimozide—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000176	0.00131	CcSEcCtD
Pimozide—Nausea—Irinotecan—pancreatic cancer	0.000175	0.00131	CcSEcCtD
Pimozide—Constipation—Docetaxel—pancreatic cancer	0.000174	0.0013	CcSEcCtD
Pimozide—Visual impairment—Doxorubicin—pancreatic cancer	0.000173	0.00129	CcSEcCtD
Pimozide—Nausea—Gemcitabine—pancreatic cancer	0.000171	0.00127	CcSEcCtD
Pimozide—Mental disorder—Epirubicin—pancreatic cancer	0.00017	0.00127	CcSEcCtD
Pimozide—Nausea—Fluorouracil—pancreatic cancer	0.000168	0.00125	CcSEcCtD
Pimozide—Eye disorder—Doxorubicin—pancreatic cancer	0.000167	0.00125	CcSEcCtD
Pimozide—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000166	0.00124	CcSEcCtD
Pimozide—Muscle spasms—Epirubicin—pancreatic cancer	0.000162	0.00121	CcSEcCtD
Pimozide—CYP3A5—islet of Langerhans—pancreatic cancer	0.000159	0.0326	CbGeAlD
Pimozide—Vision blurred—Epirubicin—pancreatic cancer	0.000159	0.00119	CcSEcCtD
Pimozide—Mental disorder—Doxorubicin—pancreatic cancer	0.000157	0.00117	CcSEcCtD
Pimozide—Anaemia—Epirubicin—pancreatic cancer	0.000156	0.00116	CcSEcCtD
Pimozide—Agitation—Epirubicin—pancreatic cancer	0.000155	0.00116	CcSEcCtD
Pimozide—Syncope—Epirubicin—pancreatic cancer	0.000151	0.00113	CcSEcCtD
Pimozide—Leukopenia—Epirubicin—pancreatic cancer	0.000151	0.00113	CcSEcCtD
Pimozide—Muscle spasms—Doxorubicin—pancreatic cancer	0.00015	0.00112	CcSEcCtD
Pimozide—CALM2—pancreas—pancreatic cancer	0.00015	0.0307	CbGeAlD
Pimozide—CALM1—pancreas—pancreatic cancer	0.000149	0.0305	CbGeAlD
Pimozide—Palpitations—Epirubicin—pancreatic cancer	0.000149	0.00111	CcSEcCtD
Pimozide—Loss of consciousness—Epirubicin—pancreatic cancer	0.000148	0.00111	CcSEcCtD
Pimozide—Vision blurred—Doxorubicin—pancreatic cancer	0.000147	0.0011	CcSEcCtD
Pimozide—Asthenia—Docetaxel—pancreatic cancer	0.000146	0.00109	CcSEcCtD
Pimozide—Convulsion—Epirubicin—pancreatic cancer	0.000146	0.00109	CcSEcCtD
Pimozide—Hypertension—Epirubicin—pancreatic cancer	0.000146	0.00109	CcSEcCtD
Pimozide—Pruritus—Docetaxel—pancreatic cancer	0.000144	0.00108	CcSEcCtD
Pimozide—Anaemia—Doxorubicin—pancreatic cancer	0.000144	0.00108	CcSEcCtD
Pimozide—Chest pain—Epirubicin—pancreatic cancer	0.000143	0.00107	CcSEcCtD
Pimozide—Myalgia—Epirubicin—pancreatic cancer	0.000143	0.00107	CcSEcCtD
Pimozide—Agitation—Doxorubicin—pancreatic cancer	0.000143	0.00107	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000143	0.00106	CcSEcCtD
Pimozide—Dry mouth—Epirubicin—pancreatic cancer	0.00014	0.00105	CcSEcCtD
Pimozide—Syncope—Doxorubicin—pancreatic cancer	0.00014	0.00104	CcSEcCtD
Pimozide—Leukopenia—Doxorubicin—pancreatic cancer	0.00014	0.00104	CcSEcCtD
Pimozide—Diarrhoea—Docetaxel—pancreatic cancer	0.00014	0.00104	CcSEcCtD
Pimozide—Palpitations—Doxorubicin—pancreatic cancer	0.000138	0.00103	CcSEcCtD
Pimozide—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000137	0.00102	CcSEcCtD
Pimozide—Shock—Epirubicin—pancreatic cancer	0.000135	0.00101	CcSEcCtD
Pimozide—Convulsion—Doxorubicin—pancreatic cancer	0.000135	0.00101	CcSEcCtD
Pimozide—Nervous system disorder—Epirubicin—pancreatic cancer	0.000135	0.00101	CcSEcCtD
Pimozide—Dizziness—Docetaxel—pancreatic cancer	0.000135	0.00101	CcSEcCtD
Pimozide—Hypertension—Doxorubicin—pancreatic cancer	0.000135	0.001	CcSEcCtD
Pimozide—Tachycardia—Epirubicin—pancreatic cancer	0.000134	0.001	CcSEcCtD
Pimozide—Skin disorder—Epirubicin—pancreatic cancer	0.000134	0.000997	CcSEcCtD
Pimozide—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000133	0.000992	CcSEcCtD
Pimozide—Chest pain—Doxorubicin—pancreatic cancer	0.000133	0.000991	CcSEcCtD
Pimozide—Myalgia—Doxorubicin—pancreatic cancer	0.000133	0.000991	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000132	0.000984	CcSEcCtD
Pimozide—Anorexia—Epirubicin—pancreatic cancer	0.000131	0.000978	CcSEcCtD
Pimozide—Dry mouth—Doxorubicin—pancreatic cancer	0.00013	0.000969	CcSEcCtD
Pimozide—Vomiting—Docetaxel—pancreatic cancer	0.00013	0.000968	CcSEcCtD
Pimozide—Rash—Docetaxel—pancreatic cancer	0.000129	0.000959	CcSEcCtD
Pimozide—Hypotension—Epirubicin—pancreatic cancer	0.000129	0.000959	CcSEcCtD
Pimozide—Dermatitis—Docetaxel—pancreatic cancer	0.000128	0.000959	CcSEcCtD
Pimozide—CALM2—digestive system—pancreatic cancer	0.000128	0.0262	CbGeAlD
Pimozide—Headache—Docetaxel—pancreatic cancer	0.000128	0.000953	CcSEcCtD
Pimozide—CALM1—digestive system—pancreatic cancer	0.000127	0.0261	CbGeAlD
Pimozide—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000125	0.000935	CcSEcCtD
Pimozide—Shock—Doxorubicin—pancreatic cancer	0.000125	0.000934	CcSEcCtD
Pimozide—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000125	0.000931	CcSEcCtD
Pimozide—Insomnia—Epirubicin—pancreatic cancer	0.000124	0.000928	CcSEcCtD
Pimozide—Tachycardia—Doxorubicin—pancreatic cancer	0.000124	0.000927	CcSEcCtD
Pimozide—Skin disorder—Doxorubicin—pancreatic cancer	0.000124	0.000922	CcSEcCtD
Pimozide—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000123	0.000918	CcSEcCtD
Pimozide—Somnolence—Epirubicin—pancreatic cancer	0.000122	0.000912	CcSEcCtD
Pimozide—CYP2C19—digestive system—pancreatic cancer	0.000122	0.0249	CbGeAlD
Pimozide—Anorexia—Doxorubicin—pancreatic cancer	0.000121	0.000905	CcSEcCtD
Pimozide—Nausea—Docetaxel—pancreatic cancer	0.000121	0.000904	CcSEcCtD
Pimozide—Decreased appetite—Epirubicin—pancreatic cancer	0.00012	0.000892	CcSEcCtD
Pimozide—Hypotension—Doxorubicin—pancreatic cancer	0.000119	0.000887	CcSEcCtD
Pimozide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000119	0.000886	CcSEcCtD
Pimozide—Constipation—Epirubicin—pancreatic cancer	0.000118	0.000878	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000116	0.000865	CcSEcCtD
Pimozide—Insomnia—Doxorubicin—pancreatic cancer	0.000115	0.000859	CcSEcCtD
Pimozide—Somnolence—Doxorubicin—pancreatic cancer	0.000113	0.000844	CcSEcCtD
Pimozide—CYP3A5—pancreas—pancreatic cancer	0.000112	0.0229	CbGeAlD
Pimozide—Decreased appetite—Doxorubicin—pancreatic cancer	0.000111	0.000826	CcSEcCtD
Pimozide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00011	0.00082	CcSEcCtD
Pimozide—Urticaria—Epirubicin—pancreatic cancer	0.000109	0.000815	CcSEcCtD
Pimozide—Constipation—Doxorubicin—pancreatic cancer	0.000109	0.000812	CcSEcCtD
Pimozide—Urticaria—Doxorubicin—pancreatic cancer	0.000101	0.000754	CcSEcCtD
Pimozide—CYP1A2—digestive system—pancreatic cancer	9.92e-05	0.0203	CbGeAlD
Pimozide—Asthenia—Epirubicin—pancreatic cancer	9.87e-05	0.000736	CcSEcCtD
Pimozide—Pruritus—Epirubicin—pancreatic cancer	9.73e-05	0.000726	CcSEcCtD
Pimozide—CYP3A5—digestive system—pancreatic cancer	9.57e-05	0.0196	CbGeAlD
Pimozide—Diarrhoea—Epirubicin—pancreatic cancer	9.41e-05	0.000702	CcSEcCtD
Pimozide—HRH1—digestive system—pancreatic cancer	9.29e-05	0.019	CbGeAlD
Pimozide—Asthenia—Doxorubicin—pancreatic cancer	9.13e-05	0.000681	CcSEcCtD
Pimozide—Dizziness—Epirubicin—pancreatic cancer	9.1e-05	0.000679	CcSEcCtD
Pimozide—Pruritus—Doxorubicin—pancreatic cancer	9e-05	0.000672	CcSEcCtD
Pimozide—CYP2E1—digestive system—pancreatic cancer	8.93e-05	0.0183	CbGeAlD
Pimozide—Vomiting—Epirubicin—pancreatic cancer	8.75e-05	0.000653	CcSEcCtD
Pimozide—Diarrhoea—Doxorubicin—pancreatic cancer	8.71e-05	0.00065	CcSEcCtD
Pimozide—Rash—Epirubicin—pancreatic cancer	8.67e-05	0.000647	CcSEcCtD
Pimozide—Dermatitis—Epirubicin—pancreatic cancer	8.67e-05	0.000647	CcSEcCtD
Pimozide—Headache—Epirubicin—pancreatic cancer	8.62e-05	0.000643	CcSEcCtD
Pimozide—ABCB1—islet of Langerhans—pancreatic cancer	8.47e-05	0.0173	CbGeAlD
Pimozide—Dizziness—Doxorubicin—pancreatic cancer	8.42e-05	0.000628	CcSEcCtD
Pimozide—Nausea—Epirubicin—pancreatic cancer	8.17e-05	0.00061	CcSEcCtD
Pimozide—Vomiting—Doxorubicin—pancreatic cancer	8.09e-05	0.000604	CcSEcCtD
Pimozide—Rash—Doxorubicin—pancreatic cancer	8.03e-05	0.000599	CcSEcCtD
Pimozide—Dermatitis—Doxorubicin—pancreatic cancer	8.02e-05	0.000598	CcSEcCtD
Pimozide—Headache—Doxorubicin—pancreatic cancer	7.97e-05	0.000595	CcSEcCtD
Pimozide—HTR2A—digestive system—pancreatic cancer	7.76e-05	0.0159	CbGeAlD
Pimozide—Nausea—Doxorubicin—pancreatic cancer	7.56e-05	0.000564	CcSEcCtD
Pimozide—CYP3A4—digestive system—pancreatic cancer	7.18e-05	0.0147	CbGeAlD
Pimozide—CYP2D6—digestive system—pancreatic cancer	7.07e-05	0.0145	CbGeAlD
Pimozide—ABCB1—pancreas—pancreatic cancer	5.95e-05	0.0122	CbGeAlD
Pimozide—ABCB1—digestive system—pancreatic cancer	5.09e-05	0.0104	CbGeAlD
Pimozide—OPRK1—Signaling Pathways—HRAS—pancreatic cancer	4.62e-06	2.91e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	4.62e-06	2.91e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CCND1—pancreatic cancer	4.61e-06	2.91e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PPARG—pancreatic cancer	4.61e-06	2.91e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	4.61e-06	2.9e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—KRAS—pancreatic cancer	4.59e-06	2.9e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CTNNB1—pancreatic cancer	4.58e-06	2.89e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—STAT3—pancreatic cancer	4.57e-06	2.88e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—STAT3—pancreatic cancer	4.57e-06	2.88e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	4.57e-06	2.88e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	4.57e-06	2.88e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—NRAS—pancreatic cancer	4.56e-06	2.88e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—NRAS—pancreatic cancer	4.56e-06	2.88e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MMP9—pancreatic cancer	4.56e-06	2.87e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—HRAS—pancreatic cancer	4.55e-06	2.87e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—KRAS—pancreatic cancer	4.55e-06	2.87e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	4.54e-06	2.86e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—PTEN—pancreatic cancer	4.53e-06	2.86e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—EGFR—pancreatic cancer	4.5e-06	2.84e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—EGFR—pancreatic cancer	4.5e-06	2.84e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	4.49e-06	2.83e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	4.49e-06	2.83e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—APOE—pancreatic cancer	4.48e-06	2.83e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MMP9—pancreatic cancer	4.48e-06	2.82e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	4.46e-06	2.81e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PTEN—pancreatic cancer	4.46e-06	2.81e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CD—pancreatic cancer	4.46e-06	2.81e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—PTEN—pancreatic cancer	4.45e-06	2.81e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PTEN—pancreatic cancer	4.45e-06	2.8e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PTEN—pancreatic cancer	4.43e-06	2.79e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	4.42e-06	2.79e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—PIK3CA—pancreatic cancer	4.42e-06	2.79e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	4.41e-06	2.78e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—KRAS—pancreatic cancer	4.4e-06	2.77e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—MYC—pancreatic cancer	4.39e-06	2.77e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—TGFB1—pancreatic cancer	4.38e-06	2.76e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	4.38e-06	2.76e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	4.35e-06	2.74e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	4.34e-06	2.74e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	4.34e-06	2.74e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—EGFR—pancreatic cancer	4.3e-06	2.71e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MYC—pancreatic cancer	4.29e-06	2.71e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PIK3CB—pancreatic cancer	4.28e-06	2.7e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PTEN—pancreatic cancer	4.28e-06	2.7e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PTEN—pancreatic cancer	4.28e-06	2.7e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	4.28e-06	2.7e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—PIK3CA—pancreatic cancer	4.28e-06	2.7e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—PIK3CA—pancreatic cancer	4.28e-06	2.7e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	4.27e-06	2.69e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—TYMS—pancreatic cancer	4.25e-06	2.68e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—KRAS—pancreatic cancer	4.25e-06	2.68e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—KRAS—pancreatic cancer	4.25e-06	2.68e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MYC—pancreatic cancer	4.25e-06	2.68e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MYC—pancreatic cancer	4.25e-06	2.68e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.24e-06	2.68e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—TGFB1—pancreatic cancer	4.24e-06	2.67e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—TGFB1—pancreatic cancer	4.24e-06	2.67e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—PIK3CA—pancreatic cancer	4.22e-06	2.66e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—SRC—pancreatic cancer	4.2e-06	2.65e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	4.2e-06	2.65e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	4.2e-06	2.65e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—PIK3CA—pancreatic cancer	4.18e-06	2.63e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—EGFR—pancreatic cancer	4.16e-06	2.62e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—EGFR—pancreatic cancer	4.16e-06	2.62e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CB—pancreatic cancer	4.15e-06	2.61e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CB—pancreatic cancer	4.15e-06	2.61e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—SRC—pancreatic cancer	4.14e-06	2.61e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—SRC—pancreatic cancer	4.13e-06	2.6e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CXCL8—pancreatic cancer	4.12e-06	2.6e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	4.09e-06	2.58e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—HRAS—pancreatic cancer	4.09e-06	2.58e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TP53—pancreatic cancer	4.08e-06	2.57e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—AKT1—pancreatic cancer	4.08e-06	2.57e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—SRC—pancreatic cancer	4.06e-06	2.56e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—KRAS—pancreatic cancer	4.06e-06	2.56e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—STAT3—pancreatic cancer	4.05e-06	2.56e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	4.05e-06	2.55e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—NRAS—pancreatic cancer	4.04e-06	2.55e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TP53—pancreatic cancer	4.04e-06	2.55e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—PIK3CA—pancreatic cancer	4.04e-06	2.55e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	4.03e-06	2.54e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	4.02e-06	2.53e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—AKT1—pancreatic cancer	4.02e-06	2.53e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	3.99e-06	2.52e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CXCL8—pancreatic cancer	3.98e-06	2.51e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CXCL8—pancreatic cancer	3.98e-06	2.51e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—STAT3—pancreatic cancer	3.98e-06	2.51e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	3.98e-06	2.51e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	3.98e-06	2.51e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—NRAS—pancreatic cancer	3.97e-06	2.5e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	3.96e-06	2.5e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—HRAS—pancreatic cancer	3.96e-06	2.49e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—HRAS—pancreatic cancer	3.96e-06	2.49e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	3.96e-06	2.49e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTGS2—pancreatic cancer	3.94e-06	2.49e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CASP3—pancreatic cancer	3.94e-06	2.48e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—KRAS—pancreatic cancer	3.93e-06	2.48e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—KRAS—pancreatic cancer	3.93e-06	2.48e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	3.92e-06	2.47e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—PIK3CA—pancreatic cancer	3.91e-06	2.46e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—PIK3CA—pancreatic cancer	3.91e-06	2.46e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	3.91e-06	2.46e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PPARG—pancreatic cancer	3.91e-06	2.46e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—HRAS—pancreatic cancer	3.9e-06	2.46e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CB—pancreatic cancer	3.88e-06	2.45e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—HRAS—pancreatic cancer	3.87e-06	2.44e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTGS2—pancreatic cancer	3.85e-06	2.43e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCND1—pancreatic cancer	3.84e-06	2.42e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CASP3—pancreatic cancer	3.81e-06	2.4e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CASP3—pancreatic cancer	3.81e-06	2.4e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CTNNB1—pancreatic cancer	3.8e-06	2.4e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MYC—pancreatic cancer	3.77e-06	2.38e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	3.76e-06	2.37e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—HRAS—pancreatic cancer	3.74e-06	2.36e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—PIK3CA—pancreatic cancer	3.73e-06	2.35e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MMP9—pancreatic cancer	3.72e-06	2.35e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCND1—pancreatic cancer	3.71e-06	2.34e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCND1—pancreatic cancer	3.71e-06	2.34e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MYC—pancreatic cancer	3.71e-06	2.34e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PTEN—pancreatic cancer	3.7e-06	2.33e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MYC—pancreatic cancer	3.7e-06	2.33e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	3.7e-06	2.33e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	3.69e-06	2.33e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—EGFR—pancreatic cancer	3.68e-06	2.32e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CTNNB1—pancreatic cancer	3.67e-06	2.32e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CTNNB1—pancreatic cancer	3.67e-06	2.32e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	3.66e-06	2.31e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	3.64e-06	2.3e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MYC—pancreatic cancer	3.64e-06	2.29e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	3.63e-06	2.29e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTGS2—pancreatic cancer	3.63e-06	2.29e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	3.63e-06	2.29e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—EGFR—pancreatic cancer	3.62e-06	2.28e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—HRAS—pancreatic cancer	3.62e-06	2.28e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—HRAS—pancreatic cancer	3.62e-06	2.28e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—AKT1—pancreatic cancer	3.61e-06	2.28e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—PIK3CA—pancreatic cancer	3.61e-06	2.27e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—PIK3CA—pancreatic cancer	3.61e-06	2.27e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MMP9—pancreatic cancer	3.6e-06	2.27e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MMP9—pancreatic cancer	3.6e-06	2.27e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PTEN—pancreatic cancer	3.58e-06	2.26e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PTEN—pancreatic cancer	3.58e-06	2.26e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	3.56e-06	2.24e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	3.56e-06	2.24e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—AKT1—pancreatic cancer	3.55e-06	2.24e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TP53—pancreatic cancer	3.52e-06	2.22e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—AKT1—pancreatic cancer	3.49e-06	2.2e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—AKT1—pancreatic cancer	3.49e-06	2.2e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—KRAS—pancreatic cancer	3.48e-06	2.19e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—APOE—pancreatic cancer	3.46e-06	2.18e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—HRAS—pancreatic cancer	3.45e-06	2.18e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—AKT1—pancreatic cancer	3.45e-06	2.17e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTEN—pancreatic cancer	3.44e-06	2.17e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—SRC—pancreatic cancer	3.43e-06	2.16e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	3.43e-06	2.16e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—KRAS—pancreatic cancer	3.42e-06	2.15e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—AKT1—pancreatic cancer	3.41e-06	2.15e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	3.37e-06	2.12e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	3.36e-06	2.12e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTEN—pancreatic cancer	3.36e-06	2.12e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—VEGFA—pancreatic cancer	3.34e-06	2.11e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—HRAS—pancreatic cancer	3.34e-06	2.1e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—HRAS—pancreatic cancer	3.34e-06	2.1e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—SRC—pancreatic cancer	3.32e-06	2.09e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—SRC—pancreatic cancer	3.32e-06	2.09e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—STAT3—pancreatic cancer	3.31e-06	2.09e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NRAS—pancreatic cancer	3.3e-06	2.08e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—AKT1—pancreatic cancer	3.3e-06	2.08e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—VEGFA—pancreatic cancer	3.24e-06	2.04e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—VEGFA—pancreatic cancer	3.24e-06	2.04e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—STAT3—pancreatic cancer	3.2e-06	2.02e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—STAT3—pancreatic cancer	3.2e-06	2.02e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	3.2e-06	2.02e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NRAS—pancreatic cancer	3.2e-06	2.01e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NRAS—pancreatic cancer	3.2e-06	2.01e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—AKT1—pancreatic cancer	3.19e-06	2.01e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—AKT1—pancreatic cancer	3.19e-06	2.01e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTEN—pancreatic cancer	3.16e-06	1.99e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	3.15e-06	1.98e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	3.14e-06	1.98e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	3.14e-06	1.98e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	3.14e-06	1.98e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PIK3CA—pancreatic cancer	3.12e-06	1.97e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.12e-06	1.97e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	3.1e-06	1.95e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TP53—pancreatic cancer	3.09e-06	1.95e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	3.09e-06	1.95e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MYC—pancreatic cancer	3.08e-06	1.94e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTGS2—pancreatic cancer	3.07e-06	1.94e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TGFB1—pancreatic cancer	3.07e-06	1.94e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—AKT1—pancreatic cancer	3.05e-06	1.92e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TP53—pancreatic cancer	3.04e-06	1.92e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TP53—pancreatic cancer	3.04e-06	1.92e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PIK3CA—pancreatic cancer	3.02e-06	1.91e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PIK3CA—pancreatic cancer	3.02e-06	1.91e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.01e-06	1.9e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—EGFR—pancreatic cancer	3.01e-06	1.9e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TP53—pancreatic cancer	2.99e-06	1.88e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MYC—pancreatic cancer	2.98e-06	1.88e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MYC—pancreatic cancer	2.98e-06	1.88e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	2.98e-06	1.88e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TGFB1—pancreatic cancer	2.97e-06	1.87e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TGFB1—pancreatic cancer	2.97e-06	1.87e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—HRAS—pancreatic cancer	2.96e-06	1.87e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—AKT1—pancreatic cancer	2.95e-06	1.86e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—AKT1—pancreatic cancer	2.95e-06	1.86e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—EGFR—pancreatic cancer	2.91e-06	1.84e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—EGFR—pancreatic cancer	2.91e-06	1.84e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	2.91e-06	1.84e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—HRAS—pancreatic cancer	2.91e-06	1.83e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	2.86e-06	1.8e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—KRAS—pancreatic cancer	2.84e-06	1.79e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KRAS—pancreatic cancer	2.75e-06	1.73e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KRAS—pancreatic cancer	2.75e-06	1.73e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.75e-06	1.73e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTEN—pancreatic cancer	2.68e-06	1.69e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—AKT1—pancreatic cancer	2.61e-06	1.65e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PIK3CA—pancreatic cancer	2.61e-06	1.65e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	2.57e-06	1.62e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—AKT1—pancreatic cancer	2.57e-06	1.62e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—AKT1—pancreatic cancer	2.57e-06	1.62e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—AKT1—pancreatic cancer	2.56e-06	1.62e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—AKT1—pancreatic cancer	2.55e-06	1.61e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TP53—pancreatic cancer	2.53e-06	1.59e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CA—pancreatic cancer	2.53e-06	1.59e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CA—pancreatic cancer	2.53e-06	1.59e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	2.52e-06	1.59e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—AKT1—pancreatic cancer	2.47e-06	1.56e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—AKT1—pancreatic cancer	2.47e-06	1.56e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TP53—pancreatic cancer	2.44e-06	1.54e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TP53—pancreatic cancer	2.44e-06	1.54e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	2.43e-06	1.53e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—HRAS—pancreatic cancer	2.42e-06	1.52e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.39e-06	1.51e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.37e-06	1.49e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CA—pancreatic cancer	2.37e-06	1.49e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—HRAS—pancreatic cancer	2.34e-06	1.47e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—HRAS—pancreatic cancer	2.34e-06	1.47e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	2.23e-06	1.41e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—AKT1—pancreatic cancer	2.13e-06	1.35e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.07e-06	1.3e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—AKT1—pancreatic cancer	2.06e-06	1.3e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—AKT1—pancreatic cancer	2.06e-06	1.3e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.98e-06	1.25e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—AKT1—pancreatic cancer	1.93e-06	1.22e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.89e-06	1.19e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.82e-06	1.15e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.54e-06	9.73e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.46e-06	9.2e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.19e-06	7.51e-06	CbGpPWpGaD
